Literature DB >> 10828871

Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia.

C A Mullen1, J N Thompson, L A Richard, K W Chan.   

Abstract

This report describes unrelated umbilical cord blood transplantation for a 10-month-old infant boy with mucopolysaccharidosis IIB (Hunter syndrome), an X-linked metabolic storage disorder due to deficiency of iduronate sulfatase. Two years after transplant approximately 55% normal plasma enzyme activity has been restored and abnormal urinary excretion of glycosaminoglycans has nearly completely resolved. The boy has exhibited normal growth and development after transplant. Nine months after transplant he developed severe autoimmune hemolytic anemia and required 14 months of corticosteroid treatment to prevent clinically significant anemia. Bone marrow transplantation for Hunter syndrome and post-transplant hemolytic anemia are reviewed. Bone Marrow Transplantation (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828871     DOI: 10.1038/sj.bmt.1702397

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  13 in total

1.  Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.

Authors:  Kristin M Page; Adam M Mendizabal; Vinod K Prasad; Paul L Martin; Suhag Parikh; Susan Wood; Gregory D Sempowski; Paul Szabolcs; Joanne Kurtzberg
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

Review 2.  Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

Authors:  Madeleine Taylor; Shaukat Khan; Molly Stapleton; Jianmin Wang; Jing Chen; Robert Wynn; Hiromasa Yabe; Yasutsugu Chinen; Jaap Jan Boelens; Robert W Mason; Francyne Kubaski; Dafne D G Horovitz; Anneliese L Barth; Marta Serafini; Maria Ester Bernardo; Hironori Kobayashi; Kenji E Orii; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-14       Impact factor: 5.742

3.  The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.

Authors:  Ibrahim Ahmed; Jun Teruya; Cristina Murray-Krezan; Robert Krance
Journal:  Pediatr Transplant       Date:  2015-03-23

4.  Effect of donor chimerism to reduce the level of glycosaminoglycans following bone marrow transplantation in a murine model of mucopolysaccharidosis type II.

Authors:  Kentaro Yokoi; Kazumasa Akiyama; Eiko Kaneshiro; Takashi Higuchi; Yohta Shimada; Hiroshi Kobayashi; Masaharu Akiyama; Makoto Otsu; Hiromitsu Nakauchi; Toya Ohashi; Hiroyuki Ida
Journal:  J Inherit Metab Dis       Date:  2014-12-13       Impact factor: 4.982

5.  Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.

Authors:  Francyne Kubaski; Hiromasa Yabe; Yasuyuki Suzuki; Toshiyuki Seto; Takashi Hamazaki; Robert W Mason; Li Xie; Tor Gunnar Hugo Onsten; Sandra Leistner-Segal; Roberto Giugliani; Vũ Chí Dũng; Can Thi Bich Ngoc; Seiji Yamaguchi; Adriana M Montaño; Kenji E Orii; Toshiyuki Fukao; Haruo Shintaku; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-01       Impact factor: 5.742

6.  Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.

Authors:  Maurizio Scarpa; Zsuzsanna Almássy; Michael Beck; Olaf Bodamer; Iain A Bruce; Linda De Meirleir; Nathalie Guffon; Encarna Guillén-Navarro; Pauline Hensman; Simon Jones; Wolfgang Kamin; Christoph Kampmann; Christina Lampe; Christine A Lavery; Elisa Leão Teles; Bianca Link; Allan M Lund; Gunilla Malm; Susanne Pitz; Michael Rothera; Catherine Stewart; Anna Tylki-Szymańska; Ans van der Ploeg; Robert Walker; Jiri Zeman; James E Wraith
Journal:  Orphanet J Rare Dis       Date:  2011-11-07       Impact factor: 4.123

Review 7.  Cord blood in regenerative medicine: do we need immune suppression?

Authors:  Neil H Riordan; Kyle Chan; Annette M Marleau; Thomas E Ichim
Journal:  J Transl Med       Date:  2007-01-30       Impact factor: 5.531

8.  Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.

Authors:  T Andrew Burrow; Nancy D Leslie
Journal:  Biologics       Date:  2008-06

9.  Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders.

Authors:  Abdalla Khalil; Irena Zaidman; Reuven Bergman; Ronit Elhasid; Myriam Weyl Ben-Arush
Journal:  ScientificWorldJournal       Date:  2014-01-19

10.  Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).

Authors:  Molly Stapleton; Francyne Kubaski; Robert W Mason; Hiromasa Yabe; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-08       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.